BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32139877)

  • 1. Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases.
    De Piano M; Manuelli V; Zadra G; Otte J; Edqvist PD; Pontén F; Nowinski S; Niaouris A; Grigoriadis A; Loda M; Van Hemelrijck M; Wells CM
    Oncogene; 2020 Apr; 39(18):3666-3679. PubMed ID: 32139877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring a role for fatty acid synthase in prostate cancer cell migration.
    De Piano M; Manuelli V; Zadra G; Loda M; Muir G; Chandra A; Morris J; Van Hemelrijck M; Wells CM
    Small GTPases; 2021 Jul; 12(4):265-272. PubMed ID: 33043786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhoU forms homo-oligomers to regulate cellular responses.
    Clayton NS; Hodge RG; Infante E; Alibhai D; Zhou F; Ridley AJ
    J Cell Sci; 2024 Jan; 137(2):. PubMed ID: 38180080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss.
    Bastos DC; Ribeiro CF; Ahearn T; Nascimento J; Pakula H; Clohessy J; Mucci L; Roberts T; Zanata SM; Zadra G; Loda M
    J Pathol; 2021 Mar; 253(3):292-303. PubMed ID: 33166087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells.
    Li X; Chen YT; Josson S; Mukhopadhyay NK; Kim J; Freeman MR; Huang WC
    PLoS One; 2013; 8(8):e70987. PubMed ID: 23951060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.
    Yoshii Y; Furukawa T; Oyama N; Hasegawa Y; Kiyono Y; Nishii R; Waki A; Tsuji AB; Sogawa C; Wakizaka H; Fukumura T; Yoshii H; Fujibayashi Y; Lewis JS; Saga T
    PLoS One; 2013; 8(5):e64570. PubMed ID: 23741342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. StarD13 differentially regulates migration and invasion in prostate cancer cells.
    Jaafar L; Fakhoury I; Saab S; El-Hajjar L; Abou-Kheir W; El-Sibai M
    Hum Cell; 2021 Mar; 34(2):607-623. PubMed ID: 33420961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion.
    Wells CM; Whale AD; Parsons M; Masters JR; Jones GE
    J Cell Sci; 2010 May; 123(Pt 10):1663-73. PubMed ID: 20406887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion.
    Dart AE; Box GM; Court W; Gale ME; Brown JP; Pinder SE; Eccles SA; Wells CM
    J Cell Biol; 2015 Nov; 211(4):863-79. PubMed ID: 26598620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
    Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
    J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epigenetic factor KDM2B regulates cell adhesion, small rho GTPases, actin cytoskeleton and migration in prostate cancer cells.
    Zacharopoulou N; Tsapara A; Kallergi G; Schmid E; Tsichlis PN; Kampranis SC; Stournaras C
    Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):587-597. PubMed ID: 29408056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma.
    Chianese U; Papulino C; Ali A; Ciardiello F; Cappabianca S; Altucci L; Carafa V; Benedetti R
    J Transl Med; 2023 Jan; 21(1):32. PubMed ID: 36650542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.
    Li L; Pilo GM; Li X; Cigliano A; Latte G; Che L; Joseph C; Mela M; Wang C; Jiang L; Ribback S; Simile MM; Pascale RM; Dombrowski F; Evert M; Semenkovich CF; Chen X; Calvisi DF
    J Hepatol; 2016 Feb; 64(2):333-341. PubMed ID: 26476289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The atypical RhoU/Wrch1 Rho GTPase controls cell proliferation and apoptosis in the gut epithelium.
    Slaymi C; Vignal E; Crès G; Roux P; Blangy A; Raynaud P; Fort P
    Biol Cell; 2019 May; 111(5):121-141. PubMed ID: 30834544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
    Migita T; Ruiz S; Fornari A; Fiorentino M; Priolo C; Zadra G; Inazuka F; Grisanzio C; Palescandolo E; Shin E; Fiore C; Xie W; Kung AL; Febbo PG; Subramanian A; Mucci L; Ma J; Signoretti S; Stampfer M; Hahn WC; Finn S; Loda M
    J Natl Cancer Inst; 2009 Apr; 101(7):519-32. PubMed ID: 19318631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour cell CD99 regulates transendothelial migration via CDC42 and actin remodelling.
    Mannion AJ; Odell AF; Taylor A; Jones PF; Cook GP
    J Cell Sci; 2021 Aug; 134(15):. PubMed ID: 34374417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a bipartite focal adhesion localization signal in RhoU/Wrch-1, a Rho family GTPase that regulates cell adhesion and migration.
    Ory S; Brazier H; Blangy A
    Biol Cell; 2007 Dec; 99(12):701-16. PubMed ID: 17620058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speckle-type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase.
    Gang X; Xuan L; Zhao X; Lv Y; Li F; Wang Y; Wang G
    Prostate; 2019 Jun; 79(8):864-871. PubMed ID: 30955223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.
    Zadra G; Ribeiro CF; Chetta P; Ho Y; Cacciatore S; Gao X; Syamala S; Bango C; Photopoulos C; Huang Y; Tyekucheva S; Bastos DC; Tchaicha J; Lawney B; Uo T; D'Anello L; Csibi A; Kalekar R; Larimer B; Ellis L; Butler LM; Morrissey C; McGovern K; Palombella VJ; Kutok JL; Mahmood U; Bosari S; Adams J; Peluso S; Dehm SM; Plymate SR; Loda M
    Proc Natl Acad Sci U S A; 2019 Jan; 116(2):631-640. PubMed ID: 30578319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and role of WASP and WAVE in Rho GTPase signalling in cancer.
    Lane J; Martin T; Weeks HP; Jiang WG
    Cancer Genomics Proteomics; 2014; 11(3):155-65. PubMed ID: 24969695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.